Non-surgical fibroid treatment in the pipeline

The U.S. Food and Drug Administration has accepted pharmaceutical company Allergan ’s application for U.S. sales of an oral treatment for uterine fibroids, a condition that causes excessive bleeding and that is most commonly treated with a hysterectomy. Two other companies, Bayer and AbbeVie, also are developing oral medications indicated to treat uterine fibroids, per The Wal l Street Journal.  Allergan (NYSE:AGN) is seeking approval for ulipristal acetate (UA), a selective progesterone receptor…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news